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Abstract
Background: A recent genome-wide association (GWA) study of U.S. Caucasians suggested that
eight single nucleotide polymorphisms (SNPs) in CTNNBL1  are associated with obesity and
increased fat mass. We analysed the respective SNPs in data from our previously published GWA
for early onset obesity (case-control design), in GWA data from a population-based cohort of
adults, and in an independent family-based obesity study. We investigated whether variants in
CTNNBL1 (including rs6013029) and in three other genes (SH3PXD2B, SLIT3 and FLJ42133,) were
associated with obesity.
Methods: The GWA studies were carried out using Affymetrix® SNP Chips with approximately
500,000 markers each. In the families, SNP rs6013029 was genotyped using the TaqMan® allelic
discrimination assay. The German case-control GWA included 487 extremely obese children and
adolescents and 442 healthy lean individuals. The adult GWA included 1,644 individuals from a
German population-based study (KORA). The 775 independent German families consisted of
extremely obese children and adolescents and their parents.
Results: We found no evidence for an association of the reported variants in CTNNBL1 with early
onset obesity or increased BMI. Further, in our family-based study we found no evidence for over-
transmission of the rs6013029 risk-allele T to obese children. Additionally, we found no evidence
for an association of SH3PXD2B, SLIT3 and FLJ42133 variants in our two GWA samples.
Conclusion: We detected no confirmation of the recent association of variants in CTNNBL1 with
obesity in a population of Central European ancestry.
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Background
Obesity is a major health problem worldwide and results
from an interplay of social, environmental and genetic
factors [1]. Genome-wide association (GWA) studies have
contributed to the identification of new polygenic vari-
ants contributing to inter-individual body mass index
(BMI) differences [2-5]. Recently, Liu et al. [6] reported
that variants in the beta catenin-like 1 gene (CTNNBL1)
were associated with increased fat mass and obesity in a
GWA conducted with 1,000 adult U.S. Caucasians. In the
same report, this observation was validated in a French
case-control sample (896 class III obese adults; BMI ≥ 40
kg/m2 and 2,916 normal weight controls; BMI < 25 kg/
m2).
Our study had two objectives. First, we aimed to replicate
the association of the obesity risk alleles (rs6013029 T-
allele, rs16986921 T-allele, rs6020712 A-allele,
rs6020846 G-allele, rs6020395 C-allele, rs16986890 G-
allele, rs6096781 C-allele, and rs6020339 C-allele) of
CTNNBL1 in two GWA data sets. Second, we explored
three other genes SH3PXD2B (rs13356223, rs10077897
and rs13436547), SLIT3 (rs17734503 and rs12654448)
and  FLJ42133  (rs7363432 and rs6095722), also men-
tioned by Liu et al. [6] in our GWAs. We analysed three
samples: (1) GWA data from 487 cases with early onset
extreme obesity and 442 controls; (2) GWA data of 1,644
individuals from a population-based adult cohort and (3)
genotyping data of the best CTNNBL1 SNP rs6013029
previously reported in [6] in a sample of 775 independent
nuclear families each comprising one or more extremely
obese offspring and both parents.
Methods
Participants and Genotyping
Case-control GWA
487 extremely obese children and adolescents (cases:
mean age 14.38 ± 3.74; BMI = 33.40 ± 6.81; BMI Z-score
= 4.63 ± 2.27; 42.9% male) and 442 healthy lean individ-
uals (controls: mean age 26.07 ± 5.79; BMI = 18.31 ± 1.10;
BMI Z-score = -1.38 ± 0.35; 38.7% male) from Germany.
The use of lean adults who were never overweight or obese
during childhood (assessed by interview [7]) as control
group reduces the chances of misclassification compared
to the use of lean children as controls that might become
overweight in adulthood. This sample was genotyped
using the Affymetrix® Genome-Wide Human SNP Array
5.0 with 440,794 markers. Details on this GWA have been
reported elsewhere [7]. The study was approved by the
local ethics committee.
Population-based GWA
KORA (Kooperative Gesundheitsforschung im Raum
Augsburg, follow up of Survey 3 (F3); 'Cooperative Health
Research in the Region of Augsburg') comprises 3,126 Ger-
man adults representative of the population within the
age range 25–74 years in Augsburg and surrounding areas
(Bavaria, Germany). 1,644 probands (mean age 52.52 ±
10.09; BMI = 27.33 ± 4.12; 48.9% male) were genotyped
using the Affymetrix® GeneChip® Human Mapping 500K
Array Set (for details on the sample see [8]). The ethics
committee of the Länderärztekammer for Bavaria
approved the study.
Family-based study
775 German families comprising 1,058 extremely obese
children and adolescents (775 index patients, 283 sib-
lings; mean age 13.88 ± 3.69; BMI 31.12 ± 6.06 kg/m2;
BMI Z-score = 3.91 ± 2.02, 45.8% male) and 1,550 parents
(mean age 42.56 ± 5.95; BMI 30.37 ± 6.29 kg/m2; BMI Z-
score = 1.68 ± 1.83) were recruited at the University of
Marburg and the University Duisburg-Essen. Participants
were genotyped for the SNP rs6013029 using the Taq-
Man® allelic discrimination assay (C_29958195_10 assay,
Applied Biosystems, Germany); the call rate was 99.7%,
with 100% concordance of duplicates. All individuals
studied are Caucasians from Central Europe, with Ger-
man ancestry. All studies were conducted in accordance
with the guidelines of The Declaration of Helsinki.
Statistics
Prior to analysis, the genotype distributions of all three
samples (case-control GWA sample, population based
GWA sample, and the family sample) were tested for devi-
ations from Hardy-Weinberg equilibrium using an exact
two-sided test [9]. The association between increased BMI
and CTNNBL1 polymorphisms in the KORA cohort was
analysed using linear regression analysis adjusted for age
and sex while logistic regression was used for data from
the case-control GWA. In both cases we used an additive
model for the risk allele as described in [6]. In our family-
based study we tested for overtransmission of the
rs6013029 "T" allele – reported in the original study as
being the risk allele – to affected offspring with the Pedi-
gree Disequilibrium Test (PDT-sum) [10] and generated a
genotype relative risk estimates using conditional logistic
regression.
Power calculations based on the effect of genetic variants
in rs6013029 were performed for the case-control and the
cohort using the program QUANTO Version 1.2.3 http://
hydra.usc.edu/gxe and for the family-based sample using
TDT Power Calculator 1.2.1 http://www.bio
stat.jhsph.edu/~wmchen/pc.html. For these calculations
we assumed a minor allele frequency = 0.05 and genetic
effect size of OR = 1.42 as estimated in [6] for the tests
which used the case-control and family setting, while a
true genetic effect of β = 0.1 (increase in mean BMI with
each additional risk allele) was chosen for the cohort. In
either case α = 0.05 (one-sided) was chosen.BMC Medical Genetics 2009, 10:14 http://www.biomedcentral.com/1471-2350/10/14
Page 3 of 6
(page number not for citation purposes)
Results and discussion
We analysed the data of both GWA studies on the SNPs
previously reported in [6] of the CTNNBL1 gene. There
was no indication of a deviation from Hardy-Weinberg
equilibrium at any of these markers in either GWA sample
or among the founders in the families based on the exact
test described above (all p-values > 0.05). Furthermore,
there was no evidence for an association of any of the
SNPs in the CTNNBL1  gene with obesity in our data
(Table 1). The strongest signal in the original report
(rs6013029) achieved a two-sided p-value of 0.53 in our
case-control GWA with an estimated odds ratio (OR) of
0.88 (95% confidence interval (CI) 0.60 – 1.30) for the
risk-allele T. Even though there is some overlap in the con-
fidence intervals when comparing our result to the results
of the original report's French case-control validation
sample with 1.42 (95% CI 1.14 – 1.77) the point estima-
tors indicate different directions of the T-allele effect.
Combined with the absence of an observed association of
this marker with BMI in the KORA cohort a false positive
initial observation is the most likely explanation (Table
1).
As rs6013029 was the main initial finding [6], we never-
theless decided to genotype this variant in 775 independ-
ent families ascertained for at least one obese offspring.
We detected no evidence for an overtransmission of the T-
allele – risk allele in the original study – to the obese off-
spring (two-sided p = 0.50), and an effect size estimate
based on this sample of genotype relative risk (GRR) =
0.933 (95% CI 0.717 – 1.214) failed to exclude unity as
well. The other CTNNBL1 SNPs previously described in
[6] are displayed in Table 1. In addition, we also tried to
explore the unvalidated results of SNPs from three addi-
tional genes (FLJ42133: rs7363432 and rs6095722;
SH3PXD2B: rs13356223, rs10077897 and rs13436547;
SLIT3: rs17734503 and rs12654448) which were also
reported to be associated with increased fat mass
(FLJ42133) or increased BMI (SH3PXD2B  and  SLIT3),
respectively (Table 2). Once again, no evidence for an
association in either of our GWAs was detected. In view of
the requirement that replication studies need to be ade-
quately powered, we assessed the power of each or our
three samples based on the parameters listed above. For
the given samples sizes our family-based replication study
Table 1: Results of the best SNPs in CTNNBL1 as previously described [6] in two independent GWAs.
Case-control1 KORA cohort2
SNP Alleles4 MAF5 
cases/
controls
Genotype distribution cases (%)/
controls (%)
Odds 
ratio 
(95% CI)
Two-
sided 
p-value
One-
sided 
p-value
MAF β 
(95% CI)
Two-
sided 
p-value
One-
sided 
p-value
rs60130293 G/T 0.057/
0.064
432(88.7)/
387
(87.6)
54(11.1)/
53(12.0)
1(0.2)/
2(0.4)
0.884
(0.603 – 
1.296)
0.528 0.736 0.051 0.1013
(-0.522 – 
0.724)
0.750 0.375
rs16986921 C/T 0.056/
0.062
433(88.9)/
388
(88.0)
53(10.9)/
51(11.6)
1(0.2)/
2(0.4)
0.899
(0.611 – 
1.324)
0.591 0.705 0.052 0.1585
(-0.463 – 
0.780)
0.617 0.309
rs6020712 G/A 0.056/
0.064
433(88.9)/
387
(87.6)
53(10.9)/
53(12.0)
1(0.2)/
2(0.4)
0.867
(0.591 – 
1.273)
0.467 0.766 0.052 0.1052
(-0.515 – 
0.725)
0.740 0.370
rs6020846 A/G 0.066/
0.070
424(87.1)/
383
(86.7)
62(12.7)/
56(12.7)
1(0.2)/
3(0.7)
0.932126
(0.649 – 
1.340)
0.704 0.648 0.060 0.0531
(-0.529 – 
0.635)
0.858 0.429
rs6020395 G/C 0.070/
0.075
418(86.2)/
376
(85.6)
66(13.6)/
60(13.7)
1(0.2)/
3(0.7)
0.927
(0.650 – 
1.320)
0.673 0.664 0.064 0.1279
(-0.444 – 
0.700)
0.661 0.331
rs16986890 A/G NA6 0.061 -0.1227
(-0.682 – 
0.436)
0.667 0.666
rs6096781 T/C 0.063/
0.055
427(87.7)/
396
(89.6)
59(12.1)/
43(9.7)
1(0.2)/
3(0.7)
1.136
(0.773 – 
1.670)
0.515 0.257 0.053 0.0956
(-0.517 – 
0.708)
0.760 0.380
rs6020339 T/C 0.372/
0.070
197(40.5)/
383 (86.6)
216(44.4)/
56/(12.7)
73(15.0)/
3 (0.7)
0.962
(0.651 – 
1.346)
0.678 0.661 0.380 -0.0032
(-0.447 – 
0.715)
0.982 0.509
1 described in Hinney et al., 2007 [7]
2 described in Wichmann et al., 2008 [8]
3 best SNP in the original report [6]
4 minor allele in bold
5MAF = minor allele frequency
6NA = Not available in the Affymetrix® Genome-Wide Human SNP Array 5.BMC Medical Genetics 2009, 10:14 http://www.biomedcentral.com/1471-2350/10/14
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had a power > 80%, the cohort had a very limited power
of about 10% while the case-control GWA had a slightly
larger power of about 54%. If the initially reported values
overestimate the true genetic effect, which is presumably
quite often the case [11], our data nevertheless contribute
to a more precise idea of the impact of CTNNBL1 variants
on obesity.
In sum, our results underline the importance of replica-
tion of GWA results in independent samples even though
independent validations may have been reported within
the same initial study. While replication of association
with obesity of intron 1 variants in FTO has been demon-
strated robustly in almost all subsequent studies compris-
ing obese adults and children [7,12-15], the study by Liu
et al. [6] was an exception as none of the intron 1 FTO
SNPs showed evidence for a body weight-related associa-
tion. Interestingly, however, the study did find some evi-
dence for an association of variants in INSIG2  with
obesity [5,16-19]. Both examples underline the difficul-
ties that arise when trying to validate, confirm and repli-
cate associations with such complex traits as obesity. Our
failure to replicate the initial findings [6] also does not
appear to be a result of population stratification. All
recruitment was done in Germany for which population
stratification effects have shown to be of minor impor-
tance [20].
Another possible explanation for a lack of replication is
that our results are mainly based on data for children and
adolescents which are different from [6] where only adults
were investigated. Again the example of FTO [6] high-
lights how validated associations found in adults with
obesity may also be present in children with extreme
obesity [3,21]. Recently, two independent studies com-
prising more than 32,000 [22] and 14,000 [23] individu-
als also did not find significant association of the
CTNNBL1 variant rs6013029 and obesity. Our study is a
replication and validation attempt with sufficient com-
bined power to independently replicate an initial finding
[6], while also providing some evidence to support the
decision not to follow-up variants that did not "survive" a
validation within the same initial report [6]. Although we
were not able to replicate the original findings, our data
may be useful for a meta-analytical assessment of the asso-
ciation of CTNNBL1 variants and obesity. A retrospective
look at the conflicting reports on INSIG2 and the recent
reports on CTNNBL1 suggests that research on mediating
and moderating variables to more comprehensively assess
phenotype-genotype relationships is urgently needed.
Table 2: Results of the best SNPs in SH3PXD2B, SLIT3 and FLJ42133 as previously described [6] in two independent GWAs.
Case-control1 KORA cohort2
Gene SNP Alleles3 MAF4 
cases/
controls
Genotype distribution 
cases (%)/controls (%)
Odds 
ratio 
(95% CI)
Two-
sided p-
value
One-
sided p-
value
MAF β 
(95% CI)
Two-
sided p-
value
One-
sided p-
value
SH3PX
D2B
rs13356
223
T/C 0.033/
0.032
454 
(93.4)/
410 
(93.8)
32(6.6)/
26 (6.0)
0/
1 (0.2)
1.029
(0.614 – 
1.722)
0.915 0.457 0.041 -0.549
(-1.235 – 
0.136)
0.116 0.942
rs10077
897
G/A 0.040/
0.036
447 
(92.0)/
411 
(93.0)
39 (8.0)/
30 (6.8)
0/
1 (0.2)
1.114
(0.690 – 
1.799)
0.658 0.329 0.046 -0.430
(-1.086 – 
0.225)
0.198 0.901
rs13436
547
G/A 0.033/
0.032
455 
(93.4)/
415 
(93.9)
32 (6.6)/
26 (5.9)
0/
1 (0.2)
1.038
(0.620 – 
1.739)
0.886 0.443 0.041 -0.486
(-1.172 – 
0.201)
0.165 0.917
SLIT3 rs17734
503
A/G 0.082/
0.072
409 
(84.0)/
380 
(86.0)
76 
(15.6)/
60 
(13.6)
2 (0.4)/
2 (0.4)
1.150
(0.814 – 
1.626)
0.428 0.214 0.086 0.358
(-0.109 – 
0.825)
0.133 0.066
rs12654
448
C/T 0.079/
0.071
410 
(84.4)/
381 
(86.2)
75 
(15.4)/
59 
(13.3)
1 (0.2)/
2 (0.5)
1.126
(0.791 – 
1.602)
0.510 0.255 0.088 0.125
(-0.352 – 
0.601)
0.608 0.304
FLJ421
33
rs73634
32
A/G 0.066/
0.070
424 
(87.1)/
383 
(86.6)
62 
(12.7)/
56/
(12.7)
1 (0.2)/
3 (0.7)
0.932
(0.649 – 
1.340)
0.704 0.648 0.057 0.234
(-0.369 – 
0.837)
0.447 0.223
rs60957
22
A/G 0.066/
0.070
422 
(87.0)/
383 
(86.6)
62 
(12.8)/
56/
(12.7)
1 (0.2)/
3 (0.7)
0.936
(0.651 – 
1.346)
0.722 0.639 0.060 0.134
(-0.447 – 
0.715)
0.651 0.325
1 described in Hinney et al., 2007 [7]
2 described in Wichmann et al., 2008 [8]
3 minor allele in bold
4MAF = minor allele frequencyBMC Medical Genetics 2009, 10:14 http://www.biomedcentral.com/1471-2350/10/14
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Conclusion
We did not detect confirmation of association of variants
in  CTNNBL1  with obesity in a population of Central
European ancestry. Further studies have to be performed
to validate or not the initial findings about the association
of CTNNBL1 variants and obesity.
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